Țară: Australia
Limbă: engleză
Sursă: Department of Health (Therapeutic Goods Administration)
cisatracurium besilate, Quantity: 2.68 mg/mL (Equivalent: cisatracurium, Qty 2 mg/mL)
Arrotex Pharmaceuticals Pty Ltd
cisatracurium besilate
Injection, solution
Excipient Ingredients: water for injections; benzenesulfonic acid
Intravenous
5
(S4) Prescription Only Medicine
Cisatracurium injection is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. It is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.
Visual Identification: Colourless, transparent solution; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 18 Months; Container Temperature: Store at 2 to 8 degrees Celsius
Licence status A
2016-04-12